SCHEMBL5077002

SCHEMBL5077002

CCCC[P+](CCCC)(CCCC)CCCC.O=S(=O)([O-])C(F)(F)C(F)OC(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5518932 0.95 DNM1 (0.36) DNM1
SCHEMBL1735953 0.92 DNM1 (0.32) DNM1
SCHEMBL5597592 0.88 DNM1 (0.30) DNM1
SCHEMBL1736138 0.86 DNM1 (0.38) DNM1
SCHEMBL357971 0.85 DNM1 (0.34) DNM1
Potassium Ion SCHEMBL2196769 0.82
SCHEMBL1735074 0.80 DNM1 (0.40) DNM1
SCHEMBL5597843 0.75 ALDH1A1 (0.30)
SCHEMBL5517313 0.75 MEN1 (0.42)
SCHEMBL123514 0.74 DNM1 (0.38) DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954658-A1 ALKYLATION OF AROMATIC COMPOUNDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2008-08-13 EP claimed
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
US-20070100184-A1 Alkylation of aromatic compounds E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US claimed
WO-2007050492-A1 ALKYLATION OF AROMATIC COMPOUNDS E. I. DU PONT DE NEMOURS AND COMPANY (US) 2007-05-03 WO claimed
US-20070100181-A1 Olefin isomerization E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed
US-20070100184-A1 Alkylation of aromatic compounds E. I. DU PONT DE NEMOURS AND COMPANY 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070100184-A1 Alkylation of aromatic compounds TYR, ALK, AHR DNM1 3341/4885
US-20070100181-A1 Olefin isomerization OSBP, OXER1, ALOX12 DNM1 607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.